Riskpilot← Back to searchSign inGet full accessMedpuls AB
ABActiveOrg 5565744462Svenljungagatan 1 Lgh 1704General medical practice activities · NACE 8621Est. 19990 employees
Revenue 2025
SEK 0
EBITDA margin
—
-15% vs 2024
Equity ratio
88.8%
Financial strength
Net profit 2025
SEK 5,7M
+11% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -43K | -15% |
| Net profit | SEK 5,7M | +11% |
| Total assets | SEK 13,1M | +6% |
| Equity | SEK 11,7M | +95% |
| Employees | 0 | — |
Legal name
Medpuls AB
Org number
5565744462
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 september 1999
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva läkarverksamhet samt handel med värdepapper jämte därmed förenlig verksamhet samt äga och förvalta fast egendom.
Address
Svenljungagatan 1 Lgh 1704
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 81 | 62 | 43 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 50 | 30 | −8 | −37 | −43 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 50 | 30 | −8 | −37 | −43 |
| Net financials | 90 | 100 | −67 | 5 142 | 5 731 |
| Profit before tax | 140 | 130 | −75 | 5 104 | 5 688 |
| Tax | −11 | −7 | — | — | — |
| Net profit | 129 | 124 | −75 | 5 104 | 5 688 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 656 | 1 761 | 12 196 | 12 361 | 13 131 |
| Equity | 824 | 948 | 872 | 5 977 | 11 665 |
| Long-term debt | 800 | 803 | 11 320 | 6 384 | 1 457 |
| Short-term debt | 32 | 11 | 3 | 0 | 9 |
| Total debt | 832 | 814 | 11 323 | 6 384 | 1 467 |
EBITDA margin
-4299700.0%
This company
15.8%
Market median
-27213391% vs market
20212025
Equity ratio
88.8%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
48.8%
This company
18.4%
Market median
+165% vs market
20212025
Net profit margin
568797800.0%
This company
8.1%
Market median
+7022194962% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medpuls AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Magnus Svensson | Board of Directors | 0 companies |
| Anna Christina Svensson | Deputy Board Member | 0 companies |
| Sara Kerstin Svensson | Deputy Board Member | 0 companies |